Myelofibrosis overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Myelofibrosis is a hematological disorder where there is replacement of bone marrow with [[collagen|collagenous connective tissue]] and progressive [[fibrosis]], or the replacement of the marrow with scar tissue. It is also classified as a myeloproliferative disorder.<ref name=overviewofmyelofibrosis1>Myelofibrosis. Dr Henry Knipe ◉ and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 7, 2016</ref><ref name=myelofibrosisoverviewwiki1>Myelofibrosis. Wikipedia 2016. https://en.wikipedia.org/wiki/Myelofibrosis. Accessed on March 7, 2016</ref>The term myelofibrosis alone usually refers to '''primary myelofibrosis (PMF)''', also known as chronic idiopathic myelofibrosis (CIMF); the terms idiopathic and primary mean that the disease is of unknown or spontaneous origin. This is in contrast with myelofibrosis that develops secondary to [[polycythemia vera]], [[essential thrombocythaemia]], [[leukemia]], or [[lymphoma]] ('''secondary myelofibrosis'''). Myelofibrosis is a form of myeloid metaplasia, which refers to a change in cell type in the blood-forming tissue of the bone marrow, and often the two terms are used synonymously.<ref name=myelofibrosisoverviewwiki1>Myelofibrosis. Wikipedia 2016. https://en.wikipedia.org/wiki/Myelofibrosis. Accessed on March 7, 2016</ref>
Myelofibrosis is a hematological disorder where there is replacement of bone marrow with [[collagen|collagenous connective tissue]] and progressive [[fibrosis]], or the replacement of the marrow with scar tissue. It is also classified as a myeloproliferative disorder.<ref name=overviewofmyelofibrosis1>Myelofibrosis. Dr Henry Knipe ◉ and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 7, 2016</ref><ref name=myelofibrosisoverviewwiki1>Myelofibrosis. Wikipedia 2016. https://en.wikipedia.org/wiki/Myelofibrosis. Accessed on March 7, 2016</ref> The term myelofibrosis alone usually refers to '''primary myelofibrosis (PMF)''', also known as chronic idiopathic myelofibrosis (CIMF); the terms idiopathic and primary mean that the disease is of unknown or spontaneous origin. This is in contrast with myelofibrosis that develops secondary to [[polycythemia vera]], [[essential thrombocythaemia]], [[leukemia]], or [[lymphoma]] ('''secondary myelofibrosis'''). Myelofibrosis is a form of myeloid metaplasia, which refers to a change in cell type in the blood-forming tissue of the bone marrow, and often the two terms are used synonymously.<ref name=myelofibrosisoverviewwiki1>Myelofibrosis. Wikipedia 2016. https://en.wikipedia.org/wiki/Myelofibrosis. Accessed on March 7, 2016</ref>


==References==
==References==

Revision as of 18:17, 14 March 2016

Myelofibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelofibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myelofibrosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myelofibrosis overview

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myelofibrosis overview

CDC on Myelofibrosis overview

Myelofibrosis overview in the news

Blogs on Myelofibrosis overview

Directions to Hospitals Treating Myelofibrosis

Risk calculators and risk factors for Myelofibrosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Myelofibrosis is a hematological disorder where there is replacement of bone marrow with collagenous connective tissue and progressive fibrosis, or the replacement of the marrow with scar tissue. It is also classified as a myeloproliferative disorder.[1][2] The term myelofibrosis alone usually refers to primary myelofibrosis (PMF), also known as chronic idiopathic myelofibrosis (CIMF); the terms idiopathic and primary mean that the disease is of unknown or spontaneous origin. This is in contrast with myelofibrosis that develops secondary to polycythemia vera, essential thrombocythaemia, leukemia, or lymphoma (secondary myelofibrosis). Myelofibrosis is a form of myeloid metaplasia, which refers to a change in cell type in the blood-forming tissue of the bone marrow, and often the two terms are used synonymously.[2]

References

  1. Myelofibrosis. Dr Henry Knipe ◉ and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 7, 2016
  2. 2.0 2.1 Myelofibrosis. Wikipedia 2016. https://en.wikipedia.org/wiki/Myelofibrosis. Accessed on March 7, 2016


Template:WikiDoc Sources